The cell death-inducing activity of the peptide containing Noxa mitochondrial-targeting domain is associated with calcium release.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 19826054.
- Also identified by DOI 10.1158/0008-5472.CAN-09-0349.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
DNA damage stabilizes the p53 tumor suppressor protein that determines the cell fate by either cell cycle arrest or cell death induction. Noxa, the BH3-only Bcl-2 family protein, was shown to be a key player in p53-induced cell death through the mitochondrial dysfunction; however, the molecular mechanism by which Noxa induces the mitochondrial dysfunction to cause cell death in response to genotoxic agents is largely unknown. Here, we show that the mitochondrial-targeting domain (MTD) of Noxa is a prodeath domain. Peptide containing MTD causes massive necrosis in vitro through cytosolic calcium increase; it is released from the mitochondria by opening the mitochondrial permeability transition pore. MTD peptide-induced cell death can be inhibited by calcium chelator BAPTA-AM. Moreover, MTD peptide shows the potent tumor-killing activities in mice by joining with tumor-homing motifs.
Medical subject headings
- Apoptosis
- Calcium
- Mitochondria
- Neoplasms, Experimental
- Proto-Oncogene Proteins c-bcl-2